Clinical trials
Completed Lymphoma trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 3 |
| Bristol-Myers Squibb | 2 |
| Celgene | 1 |
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 1 |
| Ivan S Moiseev | 1 |
| MedImmune LLC | 1 |
| National Research Center for Hematology, Russia | 1 |
| Novartis Pharmaceuticals | 1 |
| Seagen Inc. | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 13 |
| Leukemia | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Hematologic Diseases | 2 |
| Hodgkin Disease | 2 |
| Lymphoma, B-Cell | 2 |
| Lymphoma, Follicular | 2 |
| Myelodysplastic Syndromes | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| COVID-19 | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.